Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Biomarkers cerebrospinal fluid"" wg kryterium: Temat


Tytuł :
Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy
Autorzy :
Rhodius-Meester, Hanneke F. M.
van Maurik, Ingrid S.
Koikkalainen, Juha
Tolonen, Antti
Frederiksen, Kristian S.
Hasselbalch, Steen G.
Soininen, Hilkka
Herukka, Sanna-Kaisa
Remes, Anne M.
Teunissen, Charlotte E.
Barkhof, Frederik
Pijnenburg, Yolande A. L.
Scheltens, Philip
Lötjönen, Jyrki
van der Flier, Wiesje M.
Pokaż więcej
Temat :
Medicine
Science
Multidisciplinary
Internal medicine
medicine.medical_specialty
medicine
Neuropsychology
Vascular dementia
medicine.disease
Disease
Memory clinic
Appropriate Use Criteria
Frontotemporal dementia
business.industry
business
Dementia
Biomarker (medicine)
Aged
Alzheimer Disease/cerebrospinal fluid
Biomarkers/cerebrospinal fluid
Decision Support Systems, Clinical
Female
Humans
Male
Memory
Middle Aged
Patient Selection
Sensitivity and Specificity
Journal Article
Research Support, Non-U.S. Gov't
Research Article
Biology and Life Sciences
Anatomy
Body Fluids
Cerebrospinal Fluid
Medicine and Health Sciences
Physiology
Nervous System
Mental Health and Psychiatry
Alzheimer's Disease
Neurology
Neurodegenerative Diseases
Diagnostic Medicine
Biochemistry
Biomarkers
Diagnostic Radiology
Magnetic Resonance Imaging
Research and Analysis Methods
Imaging Techniques
Radiology and Imaging
Frontotemporal Dementia
Neuroscience
Psychology
Social Sciences
Cerebrovascular Diseases
Vascular Dementia
Genetics and Molecular Biology(all)
Agricultural and Biological Sciences(all)
General
Biochemistry, Genetics and Molecular Biology(all)
Źródło :
PLoS ONE, Vol 15, Iss 1, p e0226784 (2020)
Rhodius-Meester, H F M, van Maurik, I S, Koikkalainen, J, Tolonen, A, Frederiksen, K S, Hasselbalch, S G, Soininen, H, Herukka, S K, Remes, A M, Teunissen, C E, Barkhof, F, Pijnenburg, Y A L, Scheltens, P, Lötjönen, J & van der Flier, W M 2020, ' Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy ', PLoS ONE, vol. 15, no. 1, e0226784 . https://doi.org/10.1371/journal.pone.0226784
Crossref
Rhodius-Meester, H F M, van Maurik, I S, Koikkalainen, J, Tolonen, A, Frederiksen, K S, Hasselbalch, S G, Soininen, H, Herukka, S-K, Remes, A M, Teunissen, C E, Barkhof, F, Pijnenburg, Y A L, Scheltens, P, Lötjönen, J & van der Flier, W M 2020, ' Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy ', PLoS ONE, vol. 15, no. 1, e0226784 . https://doi.org/10.1371/journal.pone.0226784
PLoS ONE
PLoS ONE, 15(1):e0226784. Public Library of Science
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ca2032313358f3fe9cd3224f268f783
https://doaj.org/article/d230e97885c542eebef34abcaed775eb
Tytuł :
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study
Autorzy :
Isabelle Bos
Simon Lovestone
Wolfgang Maier
Isabel Santana
Oliver Peters
Harald Hampel
Iwona Kłoszewska
Philip Scheltens
Stephanie J.B. Vos
Inês Baldeiras
Sanna Kaisa Herukka
Alexandre de Mendonça
Lutz Frölich
Johannes Kornhuber
Pieter Jelle Visser
Johannes Berkhof
Frederik Barkhof
Dina Silva
Frans R.J. Verhey
Sebastian Palmqvist
Luiza Spiru
Ingrid S. van Maurik
Giovanni B. Frisoni
Samantha Galluzzi
Charlotte E. Teunissen
Wiesje M. van der Flier
Bruno Vellas
Hilkka Soininen
Jens Wiltfang
Stéphanie Egret
Gaël Chételat
Femke Bouwman
Flavio Nobili
Magda Tsolaki
Eckart Rüther
Oskar Hansson
Yvonne Freund-Levi
Åsa K. Wallin
Patrizia Mecocci
Pokaż więcej
Temat :
Alzheimers disease
Csf biomarkers
Dementia
Progression
Diagnosis
ddc:618.97
Aged
Aged, 80 and over
Alzheimer Disease/cerebrospinal fluid/epidemiology/pathology
Amyloid beta-Peptides/cerebrospinal fluid
Biomarkers/cerebrospinal fluid
Cognitive Dysfunction/cerebrospinal fluid/pathology
Disease Progression
Europe/epidemiology
Female
Follow-Up Studies
Hippocampus/pathology
Humans
Kaplan-Meier Estimate
Magnetic Resonance Imaging
Male
Middle Aged
Multicenter Studies as Topic/statistics & numerical data
Nerve Degeneration
Neuroimaging
North America/epidemiology
Organ Size
Peptide Fragments/cerebrospinal fluid
Phosphorylation
Prognosis
Proportional Hazards Models
Protein Processing, Post-Translational
tau Proteins/cerebrospinal fluid/chemistry
Clinical Neurology
Internal medicine
medicine.medical_specialty
medicine
business.industry
business
Cohort
Neurology
Oncology
medicine.disease
Disease
Geriatrics
Biomarker (medicine)
Precision medicine
Clinical endpoint
[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
ALZHEIMERS-DISEASE
CSF BIOMARKERS
DEMENTIA
PROGRESSION
DIAGNOSIS
Źródło :
The Lancet Neurology, Vol. 18, No 11 (2019) pp. 1034-1044
Crossref
The Lancet Neurology
The Lancet Neurology, Elsevier, 2019, 18 (11), pp.1034-1044. ⟨10.1016/S1474-4422(19)30283-2⟩
Lancet Neurology, 18(11), 1034-1044. Lancet Publishing Group
Lancet Neurology, 18(11), 1034-1044. Elsevier Science
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ff351ecfd51786971d8ded70e73a8ab
Tytuł :
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
Autorzy :
Vermunt, Lisa
Sikkes, Sietske A. M.
van den Hout, Ardo
Handels, Ron
Bos, Isabelle
van der Flier, Wiesje M.
Kern, Silke
Ousset, Pierre-Jean
Maruff, Paul
Skoog, Ingmar
Verhey, Frans R. J.
Freund-Levi, Yvonne
Tsolaki, Magda
Wallin, Asa K.
Rikkert, Marcel Olde
Soininen, Hilkka
Spiru, Luisa
Zetterberg, Henrik
Blennow, Kaj
Scheltens, Philip
Muniz-Terrera, Graciela
Visser, Pieter Jelle
Vellas, B.
Reynish, E.
Ousset, P. J.
Andrieu, S.
Burns, A.
Pasquier, F.
Frisoni, G.
Salmon, E.
Michel, J. P.
Zekry, D. S.
Boada, M.
Dartigues, J. F.
Olde-Rikkert, M. G. M.
Rigaud, A. S.
Winblad, B.
Malick, A.
Sinclair, A.
Froelich, L.
Scheltens, P.
Ribera, C.
Touchon, J.
Robert, P.
Salva, A.
Waldemar, G.
Bullock, R.
Tsolaki, M.
Rodriguez, G.
Spiru, L.
Pokaż więcej
Temat :
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Geriatrics and Gerontology
Clinical Neurology
Developmental Neuroscience
Health Policy
Epidemiology
Genotype
Internal medicine
medicine.medical_specialty
medicine
Allele
Neurology
Institutional repository
Apolipoprotein E
Dementia
medicine.disease
business.industry
business
Disease
Oncology
Cerebrospinal fluid
Alzheimer's disease
APOE
Clinical setting
Disease duration
Multistate model
Preclinical
Prodromal
Progression
ddc:618.97
Aged
Alleles
Alzheimer Disease/genetics/pathology
Amyloid
Apolipoprotein E4/genetics
Biomarkers/cerebrospinal fluid
Cognitive Dysfunction/pathology
Disease Progression
Female
Humans
Longitudinal Studies
Male
Positron-Emission Tomography
Prodromal Symptoms
Sex Factors
Time Factors
tau Proteins/cerebrospinal fluid
MILD COGNITIVE IMPAIRMENT
BETA-AMYLOID 1-42
ASSOCIATION WORKGROUPS
DIAGNOSTIC GUIDELINES
NATIONAL INSTITUTE
RISK-FACTORS
DECLINE
PREVALENCE
NEURODEGENERATION
RECOMMENDATIONS
Źródło :
Crossref
Alzheimer Disease Neuroimaging Initiative, AIBL Research Group & ICTUS/DSA study groups 2019, ' Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype ', Alzheimer's and Dementia, vol. 15, no. 7, pp. 888-898 . https://doi.org/10.1016/j.jalz.2019.04.001
Alzheimer's & Dementia, 15, 888-898
Alzheimer's & Dementia, Vol. 15, No 7 (2019) pp. 888-898
Alzheimer's and Dementia, 15(7), 888-898. Elsevier Inc.
Alzheimer's and Dementia, 15(7), 888-898. Elsevier
Alzheimer's & Dementia, 15(7), 888-898. Elsevier Science
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c03928efd25674f60e863f36648f9fe0
Tytuł :
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
Autorzy :
Kim, Min
Snowden, Stuart
Suvitaival, Tommi
Ali, Ashfaq
Merkler, David J.
Ahmad, Tahmina
Westwood, Sarah
Baird, Alison
Proitsi, Petroula
Nevado-Holgado, Alejo
Hye, Abdul
Bos, Isabelle
Vos, Stephanie
Vandenberghe, Rik
Teunissen, Charlotte
ten Kate, Mara
Scheltens, Philip
Gabel, Silvy
Meersmans, Karen
Blin, Olivier
Richardson, Jill
De Roeck, Ellen
Sleegers, Kristel
Bordet, Régis
Rami, Lorena
Kettunen, Petronella
Tsolaki, Magda
Verhey, Frans
Sala, Isabel
Lléo, Alberto
Peyratout, Gwendoline
Tainta, Mikel
Johanssen, Peter
Freund-Levi, Yvonne
Frölich, Lutz
Dobricic, Valerija
Engelborghs, Sebastiaan
Frisoni, Giovanni B.
Molinuevo, José L.
Wallin, Anders
Popp, Julius
Martinez-Lage, Pablo
Bertram, Lars
Barkhof, Frederik
Ashton, Nicolas
Blennow, Kaj
Zetterberg, Henrik
Streffer, Johannes
Visser, Pieter J.
Lovestone, Simon
Legido-Quigley, Cristina
Pokaż więcej
Temat :
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Geriatrics and Gerontology
Clinical Neurology
Developmental Neuroscience
Health Policy
Epidemiology
Amyloid
Internal medicine
medicine.medical_specialty
medicine
Cerebrospinal fluid
Neurology
Tau protein
biology.protein
biology
Biomarker discovery
Oncology
business.industry
business
Dementia
medicine.disease
Alzheimer's disease
Biomarker (medicine)
EMIF-AD
Tau
CSF
Brain volume measurements
Cognitive function measurements
Metabolomics
Biomarkers
INDUCED LIPOKINE
ACID
OLEAMIDE
MARKERS
RECOMMENDATIONS
PERTURBATIONS
BIOSYNTHESIS
13-DIHOME
METABOLISM
12,13-DIHOME
Science & Technology
Life Sciences & Biomedicine
Neurosciences & Neurology
Article
Alzheimer’s disease
ddc:618.97
ddc:616.89
Aged
Amyloid beta-Peptides/blood
Amyloid beta-Peptides/cerebrospinal fluid
Amyloidosis/blood
Amyloidosis/cerebrospinal fluid
Amyloidosis/metabolism
Biomarkers/blood
Biomarkers/cerebrospinal fluid
Brain/pathology
Cognitive Dysfunction/diagnosis
Cohort Studies
Female
Hippocampus/metabolism
Humans
Magnetic Resonance Imaging
Male
Memory/physiology
Middle Aged
Neuropsychological Tests
tau Proteins/blood
tau Proteins/cerebrospinal fluid
Biology
Human medicine
Źródło :
Crossref
Alzheimer's & Dementia, 15(6), 817-827. Elsevier Science
Alzheimer's & dementia : the journal of the Alzheimer's Association
Kim, M, Snowden, S, Suvitaival, T, Ali, A, Merkler, D J, Ahmad, T, Westwood, S, Baird, A, Proitsi, P, Nevado-Holgado, A, Hye, A, Bos, I, Vos, S, Vandenberghe, R, Teunissen, C, Ten Kate, M, Scheltens, P, Gabel, S, Meersmans, K, Blin, O, Richardson, J, De Roeck, E, Sleegers, K, Bordet, R, Rami, L, Kettunen, P, Tsolaki, M, Verhey, F, Sala, I, Lléo, A, Peyratout, G, Tainta, M, Johannsen, P, Freund-Levi, Y, Frölich, L, Dobricic, V, Engelborghs, S, Frisoni, G B, Molinuevo, J L, Wallin, A, Popp, J, Martinez-Lage, P, Bertram, L, Barkhof, F, Ashton, N, Blennow, K, Zetterberg, H, Streffer, J, Visser, P J, Lovestone, S & Legido-Quigley, C 2019, ' Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort ', Alzheimer's & Dementia, vol. 15, no. 6, pp. 817-827 . https://doi.org/10.1016/j.jalz.2019.03.004
Alzheimer's and Dementia, 15(6), 817-827. Elsevier
Alzheimer's & Dementia, Vol. 15, No 6 (2019) pp. 817-827
Alzheimer's & dementia, vol. 15, no. 6, pp. 817-827
Alzheimer's & dementia
Opis pliku :
Print-Electronic; application/pdf; pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7566425c78fd543af6a31fa0be1388dc
Tytuł :
Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis
Autorzy :
T. dos Santos, Marcia Cristina
Scheller, Dieter
Schulte, Claudia
Mesa, Irene R.
Colman, Peter
Bujac, Sarah R.
Bell, Rosie
Berteau, Caroline
Perez, Luis Tosar
Lachmann, Ingolf
Berg, Daniela
Maetzler, Walter
Nogueira da Costa, Andre
Pokaż więcej
Temat :
Multidisciplinary
Medicine
business.industry
business
Biomarker (medicine)
Internal medicine
medicine.medical_specialty
Cerebrospinal fluid
Disease
Biomarker discovery
Parkinson's disease
medicine.disease
Oncology
Univariate analysis
CSF albumin
Cohort
lcsh:Medicine
lcsh:R
lcsh:Science
lcsh:Q
Research Article
Biology and Life Sciences
Biochemistry
Biomarkers
Medicine and Health Sciences
Neurology
Neurodegenerative Diseases
Movement Disorders
Parkinson Disease
Anatomy
Body Fluids
Cerebrospinal Fluid
Physiology
Nervous System
Diagnostic Medicine
Engineering and Technology
Management Engineering
Decision Analysis
Decision Trees
Research and Analysis Methods
Computer and Information Sciences
Artificial Intelligence
Machine Learning
Physical Sciences
Mathematics
Applied Mathematics
Algorithms
Machine Learning Algorithms
Simulation and Modeling
Clinical medicine
Clinical trials
Phase II clinical investigation
Pharmacology
Drug research and development
ddc:610
Medizinische Fakultät
Faculty of Medicine
Parkinson's disease, biomarkers, cerebrospinal fluid proteins, CSF, protein markers
ddc:6
article
biomarkers
cerebrospinal fluid proteins
CSF
protein markers
Źródło :
Crossref
PLoS ONE, Vol 13, Iss 11, p e0206536 (2018)
PLoS ONE
PLOS ONE.-San Francisco : PloS one; 2018.-S.e0206536:1-e0206536:17.
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25de48fd548e2868b6006d7b6f11c4fd
Tytuł :
Implications of the International Paediatric Multiple Sclerosis Study Group consensus criteria for paediatric acute disseminated encephalomyelitis. a nationwide validation study
Autorzy :
Boesen, Magnus S
Blinkenberg, Morten
Koch-Henriksen, Nils
Thygesen, Lau C
Uldall, Peter V
Magyari, Melinda
Born, Alfred P
Pokaż więcej
Temat :
Adolescent
Biomarkers/cerebrospinal fluid
Brain/diagnostic imaging
Child
Child, Preschool
Consensus
Denmark
Encephalomyelitis, Acute Disseminated/diagnosis
Female
Follow-Up Studies
Humans
Incidence
Infant
Magnetic Resonance Imaging
Male
Multiple Sclerosis
Registries
Young Adult
SYSTEM
PROGNOSTIC-FACTORS
CNS
DEFINITIONS
DEMYELINATING DISORDERS
CHILDHOOD
CHILDREN
RELAPSE
COHORT
Clinical Neurology
Developmental Neuroscience
Pediatrics, Perinatology, and Child Health
Multiple sclerosis
medicine.disease
medicine
Not evaluated
business.industry
business
Cohort study
Acute disseminated encephalomyelitis
Pediatrics
medicine.medical_specialty
Incidence (epidemiology)
Medical record
Encephalopathy
Epidemiology
Źródło :
Boesen, M S, Blinkenberg, M, Koch-Henriksen, N, Thygesen, L C, Uldall, P V, Magyari, M & Born, A P 2018, ' Implications of the International Paediatric Multiple Sclerosis Study Group consensus criteria for paediatric acute disseminated encephalomyelitis. a nationwide validation study ', Developmental Medicine and Child Neurology, vol. 60, no. 11, pp. 1123-1131 . https://doi.org/10.1111/dmcn.13798
Crossref
Boesen, M S, Blinkenberg, M, Koch-Henriksen, N, Thygesen, L C, Uldall, P V, Magyari, M & Born, A P 2018, ' Implications of the International Paediatric Multiple Sclerosis Study Group consensus criteria for paediatric acute disseminated encephalomyelitis : A nationwide validation study ', Developmental Medicine and Child Neurology, vol. 60, no. 11, pp. 1123-1131 . https://doi.org/10.1111/dmcn.13798
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5a590aa9fa184e7babda82103735ef8
https://pure.au.dk/portal/da/publications/implications-of-the-international-paediatric-multiple-sclerosis-study-group-consensus-criteria-for-paediatric-acute-disseminated-encephalomyelitis-a-nationwide-validation-study(30e8725d-0a21-4eb2-859a-ff2e588ffdc4).html
Tytuł :
Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis
Autorzy :
Orlovska-Waast, Sonja
Köhler-Forsberg, Ole
Brix, Sophie Wiben
Nordentoft, Merete
Kondziella, Daniel
Krogh, Jesper
Benros, Michael Eriksen
Pokaż więcej
Temat :
Cellular and Molecular Neuroscience
Psychiatry and Mental health
Molecular Biology
Cerebrospinal fluid
Clinical psychology
Medicine
business.industry
business
Affect (psychology)
Meta-analysis
Schizophrenia
medicine.disease
MEDLINE
AUTOIMMUNE-DISEASES
BIPOLAR DISORDER
BLOOD-BRAIN-BARRIER
C-REACTIVE PROTEIN
CENTRAL-NERVOUS-SYSTEM
DEPRESSIVE SYMPTOMS
HERPES-SIMPLEX TYPE-1
NECROSIS-FACTOR-ALPHA
RECENT-ONSET
VIRAL ANTIBODIES
Humans
Male
Cerebrospinal Fluid/immunology
Infections/cerebrospinal fluid
Biomarkers/cerebrospinal fluid
Inflammation/cerebrospinal fluid
Schizophrenia/cerebrospinal fluid
Female
Psychotic Disorders/cerebrospinal fluid
Mood Disorders/cerebrospinal fluid
Review Article
Diagnostic markers
Depression
Journal Article
Review
Research Support, Non-U.S. Gov't
Źródło :
Crossref
Orlovska-Waast, S, Köhler-Forsberg, O, Brix, S W, Nordentoft, M, Kondziella, D, Krogh, J & Benros, M E 2019, ' Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders : a systematic review and meta-analysis ', Molecular Psychiatry, vol. 24, no. 6, pp. 869-887 . https://doi.org/10.1038/s41380-018-0220-4
Köhler-Forsberg, O 2018, ' Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis. ' Molecular Psychiatry . https://doi.org/10.1038/s41380-018-0220-4
Molecular Psychiatry
Orlovska-Waast, S, Köhler-Forsberg, O, Brix, S W, Nordentoft, M, Kondziella, D, Krogh, J & Benros, M E 2019, ' Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders : a systematic review and meta-analysis ', Molecular Psychiatry, vol. 24, no. 6, pp. 869–887 . https://doi.org/10.1038/s41380-018-0220-4
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd33310a445bf63baed444e05ccad83e
Tytuł :
Cerebrospinal fluid lactate as a marker to differentiate between community-acquired acute bacterial meningitis and aseptic meningitis/encephalitis in adults:a Danish prospective observational cohort study
Autorzy :
Buch, Kristian
Bodilsen, Jacob
Knudsen, Andreas
Larsen, Lykke
Helweg-Larsen, Jannik
Storgaard, Merete
Brandt, Christian
Wiese, Lothar
Østergaard, Christian
Nielsen, Henrik
Lebech, Anne-Mette
for the Danish Study Group for Infections in the Brain
Pokaż więcej
Temat :
Acute Disease
Adult
Aged
Area Under Curve
Biomarkers/cerebrospinal fluid
Cohort Studies
Community-Acquired Infections/cerebrospinal fluid
Data Accuracy
Diagnosis, Differential
Female
Humans
Lactic Acid/cerebrospinal fluid
Male
Meningitis, Aseptic/cerebrospinal fluid
Meningitis, Bacterial/cerebrospinal fluid
Middle Aged
Prospective Studies
ROC Curve
Sensitivity and Specificity
Spinal Puncture
Space Science
Medicine
Microbiology
FOS: Biological sciences
Cell Biology
Neuroscience
Biotechnology
Immunology
FOS: Clinical medicine
Hematology
110309 Infectious Diseases
FOS: Health sciences
Computational Biology
Infectious Diseases
Microbiology (medical)
General Immunology and Microbiology
General Medicine
Internal medicine
medicine.medical_specialty
medicine
Encephalitis
medicine.disease
business.industry
business
Acute bacterial meningitis
Cerebrospinal fluid
Cohort study
Aseptic meningitis
Prospective cohort study
Differential diagnosis
CSF lactate
Źródło :
Danish Study Group for Infections in the Brain 2018, ' Cerebrospinal fluid lactate as a marker to differentiate between community-acquired acute bacterial meningitis and aseptic meningitis/encephalitis in adults : a Danish prospective observational cohort study ', Infectious Diseases, vol. 50, no. 7, pp. 514-521 . https://doi.org/10.1080/23744235.2018.1441539
Crossref
Buch, K, Bodilsen, J, Knudsen, A, Larsen, L, Helweg-Larsen, J, Storgaard, M, Brandt, C, Wiese, L, Østergaard, C, Nielsen, H, Lebech, A M & for the Danish Study Group for Infections in the Brain 2018, ' Cerebrospinal fluid lactate as a marker to differentiate between community-acquired acute bacterial meningitis and aseptic meningitis/encephalitis in adults : a Danish prospective observational cohort study ', Infectious Diseases, vol. 50, no. 7, pp. 514-521 . https://doi.org/10.1080/23744235.2018.1441539
Buch, K, Bodilsen, J, Knudsen, A, Larsen, L, Helweg-Larsen, J, Storgaard, M, Brandt, C, Wiese, L, Østergaard, C, Nielsen, H, Lebech, A-M & Danish Study Group for Infections in the Brain 2018, ' Cerebrospinal fluid lactate as a marker to differentiate between community-acquired acute bacterial meningitis and aseptic meningitis/encephalitis in adults : a Danish prospective observational cohort study ', Infectious Diseases, vol. 50, no. 7, pp. 514-521 . https://doi.org/10.1080/23744235.2018.1441539
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5830877609542aafbdd802792ba36c8
https://pure.au.dk/portal/da/publications/cerebrospinal-fluid-lactate-as-a-marker-to-differentiate-between-communityacquired-acute-bacterial-meningitis-and-aseptic-meningitisencephalitis-in-adults(3eab88d2-df2f-4d54-91b2-0b74d9981e52).html
Tytuł :
Neurodegenerative cerebrospinal fluid biomarkers tau and amyloid beta predict functional, quality of life, and neuropsychological outcomes after aneurysmal subarachnoid hemorrhage
Autorzy :
Joswig, Holger
Korte, Wolfgang
Früh, Severin
Epprecht, Lorenz
Hildebrandt, Gerhard
Fournier, Jean-Yves
Stienen, Martin Nikolaus
Pokaż więcej
Temat :
ddc:616.8
Aged
Amyloid beta-Peptides/cerebrospinal fluid
Biomarkers/cerebrospinal fluid
Female
Humans
Male
Middle Aged
Peptide Fragments
Predictive Value of Tests
Quality of Life
Recovery of Function
Subarachnoid Hemorrhage/cerebrospinal fluid/complications/psychology
Time Factors
Treatment Outcome
tau Proteins/cerebrospinal fluid
Clinic for Neurosurgery
610 Medicine & health
Amyloid beta protein, Biomarker, Cerebrospinal fluid, Neuropsychological outcome, Subarachnoid hemorrhage, Tau protein
Clinical Neurology
General Medicine
Surgery
Subarachnoid hemorrhage
medicine.disease
medicine
Neuropsychology
Amyloid beta
biology.protein
biology
Modified Rankin Scale
Cerebrospinal fluid
Gastroenterology
medicine.medical_specialty
Verbal memory
business.industry
business
Internal medicine
Tau protein
Biomarker (medicine)
Pathology
Źródło :
Neurosurgical Review, Vol. 41, No 2 (2018) pp. 605-614
Joswig, Holger; Korte, Wolfgang; Früh, Severin; Epprecht, Lorenz; Hildebrandt, Gerhard; Fournier, Jean-Yves; Stienen, Martin Nikolaus (2018). Neurodegenerative cerebrospinal fluid biomarkers tau and amyloid beta predict functional, quality of life, and neuropsychological outcomes after aneurysmal subarachnoid hemorrhage. Neurosurgical Review, 41(2):605-614.
Crossref
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1160a910ae8447fe9e0a4cc16947f227
Tytuł :
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
Autorzy :
Anders Wallin
Sanna-Kaisa Herukka
Giovanni B. Frisoni
Kaj Blennow
Philip S. Insel
Tobias Skillbäck
Henrik Zetterberg
Oskar Hansson
Harald Hampel
Lennart Minthon
Ronald Lautner
Bob Olsson
Niklas Mattsson
Mikael Landén
Pokaż więcej
Temat :
Beta amyloid
Cerebrospinal fluid
APOE
Alzheimer’s disease
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry
lcsh:RC321-571
lcsh:Neurology. Diseases of the nervous system
lcsh:RC346-429
ddc:616.89
Adolescent
Adult
Aged
80 and over
Aging/cerebrospinal fluid/genetics
Alzheimer Disease/cerebrospinal fluid/genetics
Amyloid beta-Peptides/cerebrospinal fluid
Apolipoprotein E4/genetics
Biomarkers/cerebrospinal fluid
Cohort Studies
Female
Heterozygote
Humans
Male
Middle Aged
Peptide Fragments/cerebrospinal fluid
Prodromal Symptoms
Young Adult
Research
Cognitive Neuroscience
Clinical Neurology
Neurology
Cohort
Amyloid
Middle age
Internal medicine
medicine.medical_specialty
medicine
business.industry
business
Cognitive decline
Endocrinology
Pathology
Apolipoprotein E
Polymorphism (computer science)
Allele
Źródło :
Alzheimer's Research and Therapy
Alzheimer's Research and Therapy, BioMed Central, 2017, 9, pp.87. ⟨10.1186/s13195-017-0313-3⟩
Alzheimers Research & Therapy
Alzheimer’s Research & Therapy, Vol 9, Iss 1, Pp 1-7 (2017)
Alzheimer's Research & Therapy, Vol. 9, No 1 (2017) P. 87
Alzheimer's Research & Therapy
Crossref
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01f8851e80e57140ffaf03d276ac6c8e
https://hal.sorbonne-universite.fr/hal-01629381
Tytuł :
One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond
Autorzy :
Dayon, Loïc
Guiraud, Seu Ping
Corthésy, John
Da Silva, Laeticia
Migliavacca, Eugenia
Tautvydaitė, Domilė
Oikonomidi, Aikaterini
Moullet, Barbara
Henry, Hugues
Métairon, Sylviane
Marquis, Julien
Descombes, Patrick
Collino, Sebastiano
Martin, François-Pierre J.
Montoliu, Ivan
Kussmann, Martin
Wojcik, Jérôme
Bowman, Gene L.
Popp, Julius
Pokaż więcej
Temat :
Research
Alzheimer’s disease
Cognition
CSF
Homocysteine
Metabolomics
One-carbon metabolism
S-adenosyl-L-homocysteine
Tau
ddc:616.89
Aged
Alzheimer Disease/cerebrospinal fluid/diagnosis/epidemiology
Biomarkers/blood/cerebrospinal fluid
Carbon/blood
Carbon Compounds, Inorganic/cerebrospinal fluid
Cognition Disorders/cerebrospinal fluid/diagnosis/epidemiology
Comorbidity
Female
Homocysteine/cerebrospinal fluid
Humans
Male
Prevalence
Risk Factors
Switzerland/epidemiology
lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry
lcsh:RC321-571
lcsh:Neurology. Diseases of the nervous system
lcsh:RC346-429
Cognitive Neuroscience
Clinical Neurology
Neurology
Cognitive decline
Apolipoprotein E
Methionine
chemistry.chemical_compound
chemistry
Cystathionine beta synthase
biology.protein
biology
Hyperhomocysteinemia
medicine.disease
medicine
Alzheimer's disease
Psychology
Cerebrospinal fluid
Pathology
medicine.medical_specialty
Alzheimer Disease/cerebrospinal fluid
Alzheimer Disease/diagnosis
Alzheimer Disease/epidemiology
Biomarkers/blood
Biomarkers/cerebrospinal fluid
Cognition Disorders/cerebrospinal fluid
Cognition Disorders/diagnosis
Cognition Disorders/epidemiology
Źródło :
Alzheimer's Research & Therapy
Alzheimer's Research and Therapy, Vol. 9, No 1 (2017) P. 43
Alzheimer’s Research & Therapy, Vol 9, Iss 1, Pp 1-11 (2017)
Crossref
Alzheimer's research & therapy, vol. 9, no. 1, pp. 43
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee289c1aaef5aebd78c7bd1315c9cd32
http://europepmc.org/articles/PMC5473969
Tytuł :
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer’s Disease: Analytical and Diagnostic Characterization
Autorzy :
Piotr Lewczuk
Kaj Blennow
Armand Perret-Liaudet
Juan Manuel Maler
Lucilla Parnetti
Julius Popp
José Luis Molinuevo
Henrik Zetterberg
Philipp Spitzer
Sebastiaan Engelborghs
Ingolf Lachmann
Sebastian Brandner
Davide Chiasserini
Max Holzer
Charlotte E. Teunissen
Katharina Flach
Barbara Mroczko
Natalia Lelental
Johannes Kornhuber
Pokaż więcej
Temat :
Psychiatry and Mental health
Geriatrics and Gerontology
Clinical Psychology
General Medicine
General Neuroscience
Pathology
medicine.medical_specialty
medicine
Molecular biology
business.industry
business
Detection limit
Potential biomarkers
Immunoglobulin G
biology.protein
biology
Biomarker (medicine)
Antibody
Standard curve
Alzheimer's disease
medicine.disease
Cerebrospinal fluid
Aged
Alzheimer Disease/cerebrospinal fluid
Animals
Biomarkers/cerebrospinal fluid
Cells, Cultured
Cognitive Dysfunction/cerebrospinal fluid
Enzyme-Linked Immunosorbent Assay/methods
Epitope Mapping
Female
Humans
Male
Mice, Inbred BALB C
Phosphorylation
Protein Stability
Reproducibility of Results
Sensitivity and Specificity
Specimen Handling/methods
Temperature
tau Proteins/cerebrospinal fluid/genetics
Human medicine
mental disorders
Źródło :
Journal of Alzheimer's Disease
Crossref
Journal of Alzheimer's Disease, Vol. 55, No 1 (2017) pp. 159-170
Journal of Alzheimer's disease
Opis pliku :
pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bea197dd84f75b93e7d8659fb53c95f
https://serval.unil.ch
Tytuł :
Predicting Progression from Cognitive Impairment to Alzheimer's Disease with the Disease State Index
Autorzy :
Hall, A.
Mattila, J.
Koikkalainen, J.
Lötjonen, J.
Wolz, R.
Scheltens, P.
Giovanni B. Frisoni
Tsolaki, M.
Nobili, F.
Freund-Levi, Y.
Minthon, L.
Frölich, L.
Hampel, H.
Visser, P. J.
Soininen, H.
Pokaż więcej
Temat :
Alzheimer's disease
cerebrospinal fluid (CSF)
computer-assisted diagnosis
dementia
DESCRIPA
magnetic resonance imaging (MRI)
mild cognitive impairment (MCI)
Clinical Neurology
Neurology
Internal medicine
medicine.medical_specialty
medicine
Psychology
Cohort
Pathology
Biomarker (medicine)
Dementia
medicine.disease
Predictive value of tests
Cognitive test
Oncology
Mild cognitive impairment (MCI)
ddc:616.89
Aged
80 and over
Alzheimer Disease/cerebrospinal fluid/diagnosis/physiopathology
Apolipoproteins E/genetics
Area Under Curve
Biomarkers/cerebrospinal fluid
Cognitive Dysfunction/cerebrospinal fluid/genetics/physiopathology
Disease Progression
Europe
Female
Humans
Longitudinal Studies
Magnetic Resonance Imaging
Male
Middle Aged
Neuropsychological Tests
Predictive Value of Tests
Psychiatric Status Rating Scales
Sensitivity and Specificity
Źródło :
Current Alzheimer Research, 12(1), 69-79. Bentham Science Publishers B.V.
Hall, A, Mattila, J, Koikkalainen, J, Lötjonen, J, Wolz, R, Scheltens, P, Frisoni, G, Tsolaki, M, Nobili, F, Freund-Levi, Y, Minthon, L, Frölich, L, Hampel, H, Visser, P J & Soininen, H 2015, ' Prediction progression from cognitive impairment to alzheimer's disease with the disease state index ', Current Alzheimer Research, vol. 12, no. 1, pp. 69-79 . https://doi.org/10.2174/1567205012666141218123829
Crossref
Current Alzheimer Research, Vol. 12, No 1 (2015) pp. 69-79
Current Alzheimer Research, 12(1), 69-79. Bentham Science Publishers Ltd.
Karolinska Institutet
Scopus-Elsevier
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3607653bee7af4e01a464b763cec1d74
Tytuł :
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
Autorzy :
Simonsen, A. H.
Galluzzi, S.
Handels, R.
Kramberger, M. G.
Kulczyńska, A.
Molinuevo, J. L.
Mroczko, B.
Nordberg, A.
Oliveira, C. R.
Otto, M.
Rinne, J. O.
Herukka, S. K.
Rot, U.
Saka, E.
Soininen, H.
Struyfs, H.
Suardi, S.
Visser, P. J.
Winblad, B.
Zetterberg, H.
Waldemar, G.
Andreasen, N.
Baldeiras, I.
Bjerke, M.
Blennow, K.
Engelborghs, S.
Frisoni, G. B.
Gabryelewicz, T.
Pokaż więcej
Temat :
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Geriatrics and Gerontology
Clinical Neurology
Developmental Neuroscience
Health Policy
Epidemiology
Cost effectiveness
Disease
Csf biomarkers
Biomarker (medicine)
Psychiatry
medicine.medical_specialty
medicine
Dementia
medicine.disease
Alzheimer's disease
Intensive care medicine
Diagnostic evaluation
Tau phosphorylation
business.industry
business
Alzheiiner's disease
Biomarkers
CSF
Diagnosis
GRADE
Recommendations
ALZHEIMERS-DISEASE DIAGNOSIS
MILD COGNITIVE IMPAIRMENT
CEREBROSPINAL-FLUID TAU
COST-EFFECTIVENESS
PHOSPHORYLATED TAU
GRADING QUALITY
METAANALYSIS
GUIDELINES
MANAGEMENT
CRITERIA
ta3112
ta3124
Alzheimer Disease/cerebrospinal fluid
Amyloid beta-Peptides/cerebrospinal fluid
Biomarkers/cerebrospinal fluid
Databases, Bibliographic/statistics & numerical data
Humans
Peptide Fragments/cerebrospinal fluid
tau Proteins/cerebrospinal fluid
Journal Article
Review
ddc:616.89
Human medicine
Źródło :
Crossref
Alzheimer's & Dementia, 13(3), 274-284. Elsevier Science
Simonsen, A H, Herukka, S-K, Andreasen, N, Baldeiras, I, Bjerke, M, Blennow, K, Engelborghs, S, Frisoni, G B, Gabryelewicz, T, Galluzzi, S, Handels, R, Kramberger, M G, Kulczyńska, A, Molinuevo, J L, Mroczko, B, Nordberg, A, Oliveira, C R, Otto, M, Rinne, J O, Rot, U, Saka, E, Soininen, H, Struyfs, H, Suardi, S, Visser, P J, Winblad, B, Zetterberg, H & Waldemar, G 2017, ' Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia ', Alzheimer's & Dementia, vol. 13, no. 3, pp. 274-284 . https://doi.org/10.1016/j.jalz.2016.09.008
Alzheimer's & Dementia, Vol. 13, No 3 (2017) pp. 274-284
Alzheimers & Dementia
Alzheimer's & dementia
Alzheimer's & Dementia, 13(3), 274-284
Alzheimer's and Dementia, 13 (3) pp. 274-284. (2017)
Simonsen, A H, Herukka, S-K, Andreasen, N, Baldeiras, I, Bjerke, M, Blennow, K, Engelborghs, S, Frisoni, G B, Gabryelewicz, T, Galluzzi, S, Handels, R, Kramberger, M G, Kulczyńska, A, Molinuevo, J L, Mroczko, B, Nordberg, A, Oliveira, C R, Otto, M, Rinne, J O, Rot, U, Saka, E, Soininen, H, Struyfs, H, Suardi, S, Visser, P J, Winblad, B, Zetterberg, H & Waldemar, G 2017, ' Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia ' Alzheimer's & Dementia, vol. 13, no. 3, pp. 274-284 . DOI: 10.1016/j.jalz.2016.09.008
NARCIS
BASE (Open Access Aggregator)
Institutional Repository Universiteit Antwerpen
UCL Discovery
Copenhagen University Research Information System
Opis pliku :
application/pdf; pdf; text
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b97eeddb6ee6850c39ffb692e9d09c3
Tytuł :
Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults
Autorzy :
Ornella Cominetti
Julius Popp
Gene L. Bowman
John Corthésy
Antonio Núñez Galindo
Eugenia Migliavacca
Hugues Henry
Jérôme Wojcik
Loïc Dayon
Aikaterini Oikonomidi
Pokaż więcej
Temat :
Aged
Alzheimer Disease/blood
Alzheimer Disease/cerebrospinal fluid
Alzheimer Disease/genetics
Amyloid beta-Peptides/cerebrospinal fluid
Apolipoprotein E4/genetics
Area Under Curve
Biomarkers/blood
Biomarkers/cerebrospinal fluid
Cognitive Dysfunction/blood
Cognitive Dysfunction/cerebrospinal fluid
Cognitive Dysfunction/genetics
Cross-Sectional Studies
Enzyme-Linked Immunosorbent Assay
Female
Humans
Male
Mass Spectrometry
Peptide Fragments/cerebrospinal fluid
Phosphorylation
Proteome
Proteomics
ROC Curve
tau Proteins/cerebrospinal fluid
Alzheimer’s disease
amyloid-β
amyloidosis
biomarker
dementia
protein
tau
Psychiatry and Mental health
Geriatrics and Gerontology
Clinical Psychology
General Medicine
General Neuroscience
Amyloidosis
medicine.disease
medicine
business.industry
business
Blood plasma
Blood proteins
Cerebrospinal fluid
Pathology
medicine.medical_specialty
Dementia
Biomarker (medicine)
Źródło :
Journal of Alzheimer's disease, vol. 60, no. 4, pp. 1641-1652
Crossref
Journal of Alzheimer's Disease, Vol. 60, No 4 (2017) pp. 1641-1652
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a966e22661d220d7dba459211a2c04
https://serval.unil.ch/notice/serval:BIB_1A9D88852EEA

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies